Ambey Laboratories IPO

Ambey Laboratories Ltd

₹1,30,000 /2000 sharesMinimum Investment

Ambey Laboratories IPO Listing Details

Listed OnIssue PriceListing PriceListing Gains
--₹68.00₹85.00₹17.00 (25.00%)

Ambey Laboratories IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
4 Jul ‘24 - 8 Jul ‘24₹1,30,0002,000₹65 - ₹68
Issue SizeIPO Doc
44.68Cr
RHP PDF

About the company

Ambey Laboratories is a producer of agrochemical products aimed at crop protection, with a focus on producing "2, 4-D base chemicals". The company's manufacturing processes use technologies, such as Programmable Logic Controllers (PLC) and Supervisory Control Systems. Currently, Ambey Laboratories’ product portfolio includes 2,4-D Acid 98% TC, 2,4-D Sodium 95% SP, 2,4-D Amine in various concentrations, 2,4-D Ethyl Hexyl Ester 96% TC, 2,4-D Ethyl Ester 96% TC, and several formulations of Chlorpyriphos, Thiamethoxam, Pretilachlor, Metribuzin, Hexaconazole, and Metalaxyl. These products are manufactured for their clients, including corporations such as Aromatic Rasayan Private Limited, JR Jindal Infraprojects Private Limited, and SC Formulator Co. Ltd.;
Founded in
1985
Managing director
Mr. Arpit Gupta
Parent organisation
Ambey Laboratories Ltd

Strength and risks

Strengths
Risks
The company's manufacturing facility in Behror, Rajasthan, holds ISO 9001:2015 and ISO 14001:2015 certifications for quality, environmental, and safety practices.
Ambey Laboratories has implemented backward integration in its production processes, achieving Zero Liquid Discharge (ZLD) status. This approach minimises emissions and waste generation, showcasing the company’s commitment to sustainable practices.
The company’s total income from operations has risen consistently from Rs 81.74 crore in FY21 to Rs 84.60 crore in FY22 to Rs 104.82 crore in FY23.

Financials

*All values are in Rs. Cr
No Graph Data To Display

Application details

Apply asPrice bandApply upto
Regular65 - 68₹2 Lakh
High Networth Individual65 - 68₹2 - 5 Lakh
For Ambey Laboratories IPO, eligible investors can apply as Regular.
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.1.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ

ABOUT GROWW